Statistical Learning for Epilepsy
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how the brain processes speech, focusing on the supratemporal plane, which plays a role in hearing and understanding sounds. By using special monitoring methods during necessary medical procedures (sEEG), researchers aim to learn how the brain adapts to different speech sounds and listening situations through Dimension-Based Statistical Learning. The study seeks English-speaking individuals aged 15-25 who are already undergoing sEEG for epilepsy or language mapping and have normal hearing. As an unphased trial, it offers participants the chance to contribute to groundbreaking research on brain function and speech processing.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this protocol is safe for patients undergoing sEEG?
Research has shown that Dimension-Based Statistical Learning, particularly when combined with machine learning for epilepsy, is generally safe. For example, studies using similar machine learning methods to detect epileptic seizures have not revealed major safety issues. These studies primarily focus on model effectiveness rather than negative effects on patients.
This study also employs sEEG, a method already used in hospitals to monitor brain activity, indicating its safety in regular medical practice. Although specific safety data for Dimension-Based Statistical Learning in humans might not be detailed, the absence of reported problems in similar studies suggests confidence in its safety.12345Why are researchers excited about this trial?
Researchers are excited about the Dimension-Based Statistical Learning technique for epilepsy because it offers a fresh approach to understanding and managing seizures. Unlike traditional treatments that focus on medication or surgical interventions, this method uses advanced data analysis to interpret brain signals, potentially identifying unique patterns associated with seizure activity. By leveraging statistical learning, this technique could lead to more personalized and effective management strategies for epilepsy, offering hope for patients who haven't responded well to existing treatments.
What evidence suggests that Dimension-Based Statistical Learning might be an effective treatment for epilepsy?
Research shows that Dimension-Based Statistical Learning, which participants in this trial will experience, can enhance understanding and prediction of seizures. Studies have found that analyzing various aspects of EEG tests, which measure brain activity, provides a good estimate of seizure risk. Advanced computer techniques, such as CNN-SVM and DNN-SVM models, have successfully identified epilepsy with high accuracy. One study demonstrated that using EEG signals predicted seizures with over 99% reliability. These findings suggest that this approach could effectively aid in understanding and managing epilepsy.46789
Who Is on the Research Team?
Taylor J Abel, MD
Principal Investigator
University of Pittsburgh
Are You a Good Fit for This Trial?
This trial is for individuals aged 15-25 with epilepsy who are undergoing sEEG in the supratemporal plane and have normal hearing, vision, cognitive, and speech-language skills. They must be fluent English speakers without a history of autism or ADHD.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
sEEG-EEG Recording
Neural activity is measured via simultaneous EEG-sEEG monitoring in the supratemporal plane and other cortical regions as participants listen to acoustic stimuli with manipulated acoustic dimensions and in different listening contexts.
Behavioral Response Collection
Behavioral responses are collected as participants provide category judgments based on perceived phonemes during acoustic stimuli presentation.
Follow-up
Participants are monitored for any adverse effects or changes in neural response post-recording sessions.
What Are the Treatments Tested in This Trial?
Interventions
- Dimension-Based Statistical Learning
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
Carnegie Mellon University
Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator